Cited by 290Cell death mechanisms and regulationMitochondrial Function and PathologyCardiac Ischemia and Reperfusion

Bax regulates primary necrosis through mitochondrial dynamics

Open access
Whelan, Russell S., Konstantinidis, Klitos, Wei, An-Chi, Chen, Yun, Reyna, Denis E., Jha, Saurabh, Yang, Ying, Calvert, John W. +7 more·2012·Proceedings of the National Academy of Sciences

Abstract

The defining event in apoptosis is mitochondrial outer membrane permeabilization (MOMP), allowing apoptogen release. In contrast, the triggering event in primary necrosis is early opening of the inner membrane mitochondrial permeability transition pore (mPTP), precipitating mitochondrial dysfunction and cessation of ATP synthesis. Bcl-2 proteins Bax and Bak are the principal activators of MOMP and apoptosis. Unexpectedly, we find that deletion of Bax and Bak dramatically reduces necrotic injury during myocardial infarction in vivo. Triple knockout mice lacking Bax/Bak and cyclophilin D, a key regulator of necrosis, fail to show further reduction in infarct size over those deficient in Bax/Bak. Absence of Bax/Bak renders cells resistant to mPTP opening and necrosis, effects confirmed in isolated mitochondria. Reconstitution of these cells or mitochondria with wild-type Bax, or an oligomerization-deficient mutant that cannot support MOMP and apoptosis, restores mPTP opening and necrosis, implicating distinct mechanisms for Bax-regulated necrosis and apoptosis. Both forms of Bax restore mitochondrial fusion in Bax/Bak-null cells, which otherwise exhibit fragmented mitochondria. Cells lacking mitofusin 2 (Mfn2), which exhibit similar fusion defects, are protected to the same extent as Bax/Bak-null cells. Conversely, restoration of fused mitochondria through inhibition of fission potentiates mPTP opening in the absence of Bax/Bak or Mfn2, indicating that the fused state itself is critical. These data demonstrate that Bax-driven fusion lowers the threshold for mPTP opening and necrosis. Thus, Bax and Bak play wider roles in cell death than previously appreciated and may be optimal therapeutic targets for diseases that involve both forms of cell death.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1201608109

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Whelan, R. S., Konstantinidis, K., Wei, A.-C., Chen, Y., Reyna, D. E., Jha, S., Yang, Y., Calvert, J. W., Lindsten, T., Thompson, C. B., Crow, M. T., Gavathiotis, E., Dorn, G. W., O'Rourke, B., & Kitsis, R. N.
Affiliations
  • Yeshiva University (US)
  • Johns Hopkins University (US)
  • Washington University in St. Louis (US)
  • Emory University (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Albert Einstein College of Medicine (US)
Venue
Proceedings of the National Academy of Sciences
Published
2012-04-09
Volume
109
Issue
17
Pages
6566-6571
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2047322721
Cited by
290
References
37
Citations by year
2026: 6 · 2025: 19 · 2024: 13 · 2023: 17 · 2022: 10 · 2021: 14 · 2020: 20 · 2019: 27 · 2018: 13 · 2017: 20 · 2016: 18 · 2015: 30 · 2014: 34 · 2013: 33 · 2012: 16
FWCI
14.52
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (T32AG023475)
  • National Heart, Lung, and Blood Institute (R01HL098481, 5R01HL60665-13, R00HL095929, R37HL054598, R01HL060665, R01HL059888)
  • National Cancer Institute (P30CA013330)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020541)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
Keywords
Bax, Bak, mitochondrial permeability transition pore, mitochondrial dynamics, mitochondrial fusion, mitofusin 2, mitochondrial fission, mitochondrial dysfunction, cyclophilin D, myocardial infarction, apoptosis, Bcl-2 family proteins, cell death
MeSH terms
Adenosine Triphosphate, Animals, Mitochondria, Myocardial Infarction, Necrosis, Mice, Knockout, bcl-2-Associated X Protein, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review